Medipharm Labs Corp T.LABS

Alternate Symbol(s): MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.

TSX:LABS - Post by User

Medipharm Labs Corp > First

<< Previous

Bullboard Posts

Next >>

Comment by Starkickeron Jul 24, 2024 10:15am

82 Views

Post# 36146021

RE:RE:RE:RE:RE:RE:First

I agree there is potential, whether realized or not. However, when the CEO complains the SP is undervalued but offers no guidance or reasons to help improve it, it tells me there is no catalyst at the present time. I hope for all shareholders that have been so patient that something triggers a rise in SP soon.

<< Previous

Bullboard Posts

Next >>

Crypto and blockchain stock ends year with a profit